Skip to main content

Advertisement

Table 2 Incidence rate ratio estimates for the considered interventions based on pair-wise meta-analysis (PMA) and network meta-analysis (NMA)

From: The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD

Intervention Rate ratios (95% CrI)
PMA NMA
Placebo   
ICS 0.81 (0.68-0.95) 0.81 (0.72-0.91)
LABA 0.87 (0.75-1.01) 0.87 (0.78-0.96)
ICS + LABA 0.71 (0.60-0.88) 0.70 (0.62-0.79)
LAMA 0.73 (0.59-0.91) 0.74 (0.67-0.82)
  1. PTC: pairwise treatment comparison, MTC: multiple treatment comparison, CrI: credible interval.